# A Long-term Follow-up Study Evaluating Intravenous Injection of EXG001-307 in Patients With Type 1 SMA

> **NCT06588803** · — · ENROLLING_BY_INVITATION · sponsor: **Guangzhou Jiayin Biotech Ltd** · enrollment: 18 (estimated)

## Conditions studied

- Spinal Muscular Atrophy

## Interventions

- **OTHER:** No intervention, only for observational studies

## Key facts

- **NCT ID:** NCT06588803
- **Lead sponsor:** Guangzhou Jiayin Biotech Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-03
- **Primary completion:** 2030-09-10
- **Final completion:** 2030-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06588803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06588803, "A Long-term Follow-up Study Evaluating Intravenous Injection of EXG001-307 in Patients With Type 1 SMA". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06588803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*